Japan Times: Tokyo-based fund CEO leads public-private fight against diseases around globe
Japan Times: Aiming for truly universal health coverage
Nikkei Asian Review: Sharing Japan's vision for global health
Asahi Shimbun: 2030 CREATING FUTURE: Japan can lead the world in ending infectious diseases
Forbes JAPAN: A special feature on the GHIT Fund
Forbes JAPAN: Special Interview to Bill Gates
Nikkei Asian Review: Access to health care key to sustained development
Financial Times: Zika threat demands a global response
Japanese Prime Minister Shinzo Abe’s comment in the Lancet
Deutsche Welle: Global health fund CEO: 'The Ebola crisis was a wakeup-call'
Nature Reviews Drug Discovery: Hit and lead criteria in drug discovery for infectious diseases of the developing world
Japan’s leadership is critical to eliminating NTDs
New York Times: Japanese Companies Attack Neglected Diseases
Forbes: Investing In Drugs That Won't Make Money
Science "Japanese foundation joins the public health Grand Challenge bandwagon"
Japanese drugmakers addressing neglected tropical diseases, and not just out of altruism
Dr. Slingsby was interviewed by Toyo Keizai Online
Professor Peter Piot, 2014 TIME Person of the Year: "The Ebola Fighters"
The National Bureau of Asian Research: The Current Ebola Outbreak: Implications for Asia and Global Health Innovation
Devex impact: How to forge successful R&D partnerships
Dr. Slingsby was interviewed by Nikkei
Professor. Peter Piot's article on the Ebola epidemic
The op-ed by Dr. Slingsby in the Asahi Shimbun
Nature"GHIT Fund 1st Anniversary Event"
SciDev Q&A: A partnership to eradicate malaria